BACKGROUND AND OBJECTIVES:People receiving treatment for multidrug-resistant tuberculosis (MDR-TB) have high rates of depression. Psychosocial support in general, and treatments for depression in particular, form an important but neglected area of patient-centred care, and a key pillar in the global End TB strategy. We assessed the feasibility and acceptability of a psychosocial support package for people receiving treatment for MDR-TB in Nepal. METHODS:This feasibility study used a mixed quantitative and qualitative approach. We implemented the intervention package in two National Tuberculosis Programme (NTP) MDR-TB treatment centres and 8 sub-centres. We screened patients monthly for depression and anxiety (cut-off ≥24 and ≥17 respectivel...
Background: The Worldwide resistance prevalence of the first-line TB drug, rifampicin (RR-TB), in 20...
Purpose: Multidrug-resistant tuberculosis (MDR-TB) patients have few adverse effects due to treatmen...
Setting: A global survey of National Tuberculosis Program (NTP) directors.Objectives: To assess the ...
Background and objectives People receiving treatment for multidrug-resistant tuberculosis (MDR-TB...
BACKGROUND AND OBJECTIVES: People receiving treatment for multidrug-resistant tuberculosis (MDR-TB) ...
Multi-drug-resistant tuberculosis (MDR-TB) poses a major threat to public health worldwide, particul...
Multi-drug-resistant tuberculosis (MDR-TB) poses a major threat to public health worldwide, particul...
The successful treatment of multidrug-resistant tuberculosis (MDR-TB) is a global health priority an...
Purpose: Multidrug-resistant tuberculosis (MDR-TB) patients have few adverse effects due to treatmen...
Background: Limited treatment options, long duration of treatment and associated toxicity adversely ...
Background: Only 55% of multidrug-resistant tuberculosis (MDR-TB) cases worldwide complete treatment...
Multi-Drug Resistant Tuberculosis (MDR-TB) is a condition of resistance to isoniazid and rifampicin ...
Based on the outcome of a previous qualitative study in the same setting it was hypothesized that as...
BACKGROUND In the new Stop TB Strategy for Tuberculosis (TB) Care, direct observation of treatment ...
Abstract Background In the new Stop TB Strategy for Tuberculosis (TB) Care, direct observation of tr...
Background: The Worldwide resistance prevalence of the first-line TB drug, rifampicin (RR-TB), in 20...
Purpose: Multidrug-resistant tuberculosis (MDR-TB) patients have few adverse effects due to treatmen...
Setting: A global survey of National Tuberculosis Program (NTP) directors.Objectives: To assess the ...
Background and objectives People receiving treatment for multidrug-resistant tuberculosis (MDR-TB...
BACKGROUND AND OBJECTIVES: People receiving treatment for multidrug-resistant tuberculosis (MDR-TB) ...
Multi-drug-resistant tuberculosis (MDR-TB) poses a major threat to public health worldwide, particul...
Multi-drug-resistant tuberculosis (MDR-TB) poses a major threat to public health worldwide, particul...
The successful treatment of multidrug-resistant tuberculosis (MDR-TB) is a global health priority an...
Purpose: Multidrug-resistant tuberculosis (MDR-TB) patients have few adverse effects due to treatmen...
Background: Limited treatment options, long duration of treatment and associated toxicity adversely ...
Background: Only 55% of multidrug-resistant tuberculosis (MDR-TB) cases worldwide complete treatment...
Multi-Drug Resistant Tuberculosis (MDR-TB) is a condition of resistance to isoniazid and rifampicin ...
Based on the outcome of a previous qualitative study in the same setting it was hypothesized that as...
BACKGROUND In the new Stop TB Strategy for Tuberculosis (TB) Care, direct observation of treatment ...
Abstract Background In the new Stop TB Strategy for Tuberculosis (TB) Care, direct observation of tr...
Background: The Worldwide resistance prevalence of the first-line TB drug, rifampicin (RR-TB), in 20...
Purpose: Multidrug-resistant tuberculosis (MDR-TB) patients have few adverse effects due to treatmen...
Setting: A global survey of National Tuberculosis Program (NTP) directors.Objectives: To assess the ...